Sigma Planning Corp’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Sigma Planning Corp’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9,295	Closed	-$234K	–	1018
2018 Q2	$234K	Buy	+9,295	New	+$230K	0.02%	761

Other funds holding LDRS

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

Sigma Planning Corp's LDRS Position: Q3 2018 in Review

Sigma Planning Corp sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q3 2018, closing a stake of 9,295 shares — an estimated $234K sold.

Sigma Planning Corp first reported a position in LDRS in Q2 2018 and held it in 1 quarter. The position peaked at $234K in Q2 2018. 18 funds tracked by Wall St. Rank hold LDRS as of Q3 2018.

Sigma Planning Corp reported no remaining Innovator IBD ETF Leaders ETF position as of Q3 2018 after selling out during the quarter.
Sigma Planning Corp sold 9,295 Innovator IBD ETF Leaders ETF shares in Q3 2018, an estimated $234K.
Sigma Planning Corp first reported a position in Innovator IBD ETF Leaders ETF in Q2 2018 and held it in 1 quarter.
Sigma Planning Corp's Innovator IBD ETF Leaders ETF position peaked at $234K in Q2 2018.
18 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q3 2018.

Based on Sigma Planning Corp's 13F filing for Q3 2018, filed 7 Nov 2018.